| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | -3.95% | Wells Fargo | $9 → $8.5 | Downgrades | Overweight → Equal-Weight |
| 08/16/2023 | 7.34% | Compass Point | $8.5 → $9.5 | Maintains | Buy |
| 08/11/2023 | 4.52% | Wells Fargo | $7.75 → $9.25 | Maintains | Overweight |
| 05/08/2023 | 1.69% | Keefe, Bruyette & Woods | $10 → $9 | Maintains | Market Perform |
| 04/18/2023 | -12.43% | Wells Fargo | $9.75 → $7.75 | Maintains | Overweight |
| 02/27/2023 | 10.17% | Wells Fargo | $10 → $9.75 | Maintains | Overweight |
| 11/21/2022 | 24.29% | Raymond James | $11.5 → $11 | Maintains | Outperform |
| 11/14/2022 | 12.99% | Wells Fargo | $9 → $10 | Maintains | Overweight |
| 11/14/2022 | 12.99% | Keefe, Bruyette & Woods | $10.5 → $10 | Downgrades | Outperform → Market Perform |
| 10/24/2022 | 1.69% | Wells Fargo | $10.5 → $9 | Maintains | Overweight |
| 08/11/2022 | 29.94% | Raymond James | $12.5 → $11.5 | Downgrades | Strong Buy → Outperform |
| 05/09/2022 | 35.59% | Wells Fargo | $12.5 → $12 | Maintains | Overweight |
| 04/25/2022 | 41.24% | Wells Fargo | $13 → $12.5 | Maintains | Overweight |
| 11/11/2021 | 41.24% | Raymond James | $12 → $12.5 | Maintains | Strong Buy |
| 10/08/2021 | 35.59% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 01/21/2021 | 24.29% | Jefferies | $9 → $11 | Upgrades | Hold → Buy |
| 08/18/2020 | 12.99% | Keefe, Bruyette & Woods | $9 → $10 | Upgrades | Market Perform → Outperform |
| 06/24/2020 | 7.34% | Raymond James | → $9.5 | Upgrades | Outperform → Strong Buy |
| 05/04/2020 | -3.95% | Compass Point | → $8.5 | Upgrades | Neutral → Buy |
| 04/02/2020 | -3.95% | Compass Point | → $8.5 | Downgrades | Buy → Neutral |
| 03/25/2020 | -18.08% | Wells Fargo | $11 → $7.25 | Maintains | Overweight |
| 10/23/2019 | 12.99% | National Securities Corporation | → $10 | Initiates Coverage On | → Neutral |
| 03/11/2019 | 24.29% | Wells Fargo | → $11 | Reinstates | → Outperform |
| 03/01/2019 | — | Compass Point | Upgrades | Neutral → Buy | |
| 02/04/2019 | — | Compass Point | Initiates Coverage On | → Neutral |
What is the target price for Barings BDC (BBDC)?
The latest price target for Barings BDC (NYSE: BBDC) was reported by Wells Fargo on November 13, 2023. The analyst firm set a price target for $8.50 expecting BBDC to fall to within 12 months (a possible -3.95% downside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Barings BDC (BBDC)?
The latest analyst rating for Barings BDC (NYSE: BBDC) was provided by Wells Fargo, and Barings BDC downgraded their equal-weight rating.
When is the next analyst rating going to be posted or updated for Barings BDC (BBDC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Barings BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Barings BDC was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Barings BDC (BBDC) correct?
While ratings are subjective and will change, the latest Barings BDC (BBDC) rating was a downgraded with a price target of $9.00 to $8.50. The current price Barings BDC (BBDC) is trading at is $8.85, which is out of the analyst's predicted range.
